Middle East & Africa Basal Cell Carcinoma Treatment Market Size & Outlook

The basal cell carcinoma treatment market in Middle East & Africa is expected to reach a projected revenue of US$ 58.2 million by 2030. A compound annual growth rate of 8.7% is expected of Middle East & Africa basal cell carcinoma treatment market from 2024 to 2030.
Revenue, 2023 (US$M)
$32.5
Forecast, 2030 (US$M)
$58.2
CAGR, 2024 - 2030
8.7%
Report Coverage
Middle East & Africa

Middle East & Africa basal cell carcinoma treatment market, 2018-2030 (US$M)

Middle

Related Markets

MEA basal cell carcinoma treatment market highlights

  • The MEA basal cell carcinoma treatment market generated a revenue of USD 32.5 million in 2023.
  • The market is expected to grow at a CAGR of 8.7% from 2024 to 2030.
  • In terms of segment, surgery was the largest revenue generating type in 2023.
  • Intralesional injections is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, South Africa is expected to register the highest CAGR from 2024 to 2030.


MEA data book summary

Market revenue in 2023USD 32.5 million
Market revenue in 2030USD 58.2 million
Growth rate8.7% (CAGR from 2023 to 2030)
Largest segmentSurgery
Fastest growing segmentIntralesional injections
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationRadiotherapy (RT), Intralesional injections, Intravenous Medications, Chemical peeling treatment, Surgery, Topical chemotherapy, Oral Medications
Key market players worldwideBausch Health Companies Inc, Almirall SA, Genentech, Novartis AG ADR, Regeneron Pharmaceuticals Inc, Dr Reddy's Laboratories Ltd ADR, Taro Pharmaceuticals, Accord Healthcare


Other key industry trends

  • In terms of revenue, MEA region accounted for 1.1% of the global basal cell carcinoma treatment market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 818.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Basal Cell Carcinoma Treatment Market Companies

Name Profile # Employees HQ Website

Middle East & Africa basal cell carcinoma treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to basal cell carcinoma treatment market will help companies and investors design strategic landscapes.


Surgery was the largest segment with a revenue share of 36% in 2023. Horizon Databook has segmented the Middle East & Africa basal cell carcinoma treatment market based on radiotherapy (rt), intralesional injections, intravenous medications, chemical peeling treatment, surgery, topical chemotherapy, oral medications covering the revenue growth of each sub-segment from 2018 to 2030.


The basal cell carcinoma treatment market in the Middle East and Africa (MEA) is witnessing steady growth due to several factors, such as increasing incidence of skin cancer, rising awareness about early detection, advancements in diagnostic technologies, and growing initiatives for skin cancer prevention & control. 

The rise in skin cancer incidence can be attributed to changing lifestyles, insufficient sun protection measures, and environmental factors. The MEA offers significant opportunities for growth in the basal cell carcinoma treatment market, mainly due to the need for more structured screening programs in less developed African countries. 

However, countries such as the UAE, Morocco, and South Africa have initiated organized cancer screening efforts in recent years. Furthermore, collaborations between companies and government bodies to facilitate these screenings are expected to propel market expansion. 

Reasons to subscribe to Middle East & Africa basal cell carcinoma treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Middle East & Africa basal cell carcinoma treatment market databook

  • Our clientele includes a mix of basal cell carcinoma treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa basal cell carcinoma treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa basal cell carcinoma treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

MEA basal cell carcinoma treatment market size, by country, 2018-2030 (US$M)

Middle East & Africa Basal Cell Carcinoma Treatment Market Outlook Share, 2023 & 2030 (US$M)

MEA basal cell carcinoma treatment market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more